MedPath

Evaluation of the LUSHA Digital Application for Children With ADHD - Feasibility Study

Not Applicable
Not yet recruiting
Conditions
Attention Deficit Disorder With or Without Hyperactivity (ADHD)
Children
Registration Number
NCT07204873
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by a triad of symptoms combining inattention, hyperactivity, and/or impulsivity. It causes developmental and functional disturbances (cognitive, behavioral, and emotional) that have a detrimental impact on the child's family, school, and/or social life. Treatment requires psychoeducation for the child and their parents, individual treatment for the child, and finally family treatment, particularly through specific parenting skills training programs (such as the Barkley program, 1997). It is sometimes necessary to combine this with medication (psychostimulants).

This care pathway can be complex to implement in practice, due to lack of regional actors (CMPPs, medical-psychological-educational centers) and a decrease in the number of child psychiatrists in hospital services.

Recently, digital applications enabling the digitization of the psychotherapeutic approach have been developed to complement and reinforce the care provided to these children, offering an immediately available non-pharmacological alternative.

LUSHA is a digital application (digital game) developed in collaboration with healthcare professionals. It aims to motivate the children to change their behavior and help parents to interact with them.

The goal of this observational study is to evaluate the adoption of LUSHA app by children with Attention deficit disorder with or without Hyperactivity (ADHD) and their parents :

* The primary objective of this study is to assess adherence/use of a digital application among children with ADHD and their parents over a period of 90 days

* The secondary objectives are to assess the clinical impact of the LUSHA digital application using validated questionnaires (i.e quality of life, behavioural, family functioning).

Participating children and their parents will be asked to use the LUSHA digital application during 3 months and to answer online surveys.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Children aged 7-12 years
  • Already diagnosed with ADHD
  • Consulting in a participating center
  • No indication of treatment changes (no treatment or medication stabilized for 2 months)
  • Family with a smartphone compatible with downloading the app
  • Non-opposition of both parents and the child (if possible)
Exclusion Criteria
  • Parent under guardianship or deprived of liberty

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
To evaluate the use of the LUSHA app among children and their parents at 3 months.90 days

Use is defined as a cumulative usage of more than 30 minutes per week on average within 3 months (90 days) of app installation.

Secondary Outcome Measures
NameTimeMethod
To evaluate the use of the LUSHA app by children and their parents at 1 and 2 months.30, 60 days

Use is defined as a cumulative usage of more than 30 minutes per week on average within 30 and 60 days of app installation.

To evaluate the quality of life (familial impact) before/after using the appInclusion, 30, 60, 90 days

Number and proportion of children with functional impairment identified by the WFIRS-P parent questionnaire (Weiss Functional Impairment Rating Scale - Parent report; CADDRA, 2011)

To evaluate the evolution of the 5 questions of the app7, 30, 60, 90 days

Average rating of responses to each of the 5 questions in the app (questions are asked directly in the application). Each question is rated from 1 to 10.

To evaluate behavioral impact before/after using LUSHA appInclusion, 30, 60, 90 days

Number and proportion of children with behavioral abnormalities identified by the SNAP IV questionnaire (average sub-scores and overall scores) completed by parents (Swanson, Nolan, and Pelham Questionnaire - Swanson et al., 1999)

To evaluate the quality of life as assessed by the child before/after using the appInclusion, 30, 60, 90 days

Overall, physical health, and psychosocial health (emotional + social + academic) mean scores on the questionnaire (PedsQL™ 4.0) Pediatric Quality of Life Inventory Version 4.0 Parent and child version (Varni et al, 2003), pediatric quality of life inventory (Appendix 3)

Appropriation of the functionnalities of the app by children and parents30, 60, and 90 days

Description of the number of validated routines, modules on emotion management, modules on the Barkley program

Association between the clinical presentation of children with ADHD and comorbidities and use of the LUSHA app90 days

Measurement of associations between average weekly usage, number of validated routines, modules completed on emotion management, modules completed on the Barkley program, and scores obtained on various questionnaires (WFIRS, SNAP, PedsQL)

Association between appropriation of the various functionalities of the app by children and parents and the familial impact, behavioral impact, and quality of life as assessed by the child.90 days

Measurement of associations between average weekly usage time, number of validated routines, modules completed on emotion management, modules completed on the Barkley program, and scores obtained on various questionnaires (WFIRS, SNAP, PedsQL)

Trial Locations

Locations (2)

University Hospital, Grenoble

🇫🇷

Grenoble, France

University Hospital, Montpellier

🇫🇷

Montpellier, France

University Hospital, Grenoble
🇫🇷Grenoble, France
Stéphanie BIOULAC, Pr, MD
Contact
(0)4 76 76 54 19
sbioulac@chu-grenoble.fr
Isabelle BOUDRY, PhD
Contact
(0)4 76 76 66 45
iboudry@chu-grenoble.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.